Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. The key components of a well-designed wearable: Sense, analyze, act
One of the earliest uses of a wearable technology was recorded during Emperor Nero’s rule over the Roman Empire from 54 to 68 AD. A brutal leader, the emperor enjoyed watching his gladiators fight in crowded stadiums. As Nero watched his fighters battle, he was confronted with a problem – the glaring sun made it difficult to see. He was fashioned a pair of spectacles made out of a polished green gem to protect his eyes and to make it easier to watch the bloody fights unfold.
Fast forward to modern day and wearables look a lot different – from the FitBit to smart watches, wearables and digital health are ushering in an era of big data and personalized solutions to health problems. Read more
4. Slow enrollment delays Nexstim pivotal trial
Nexstim said today that slow enrollment in pivotal trial of its Navigated Brain Therapy transcranial magnetic stimulation device in treating patients rehabilitating from stroke.
The 60-patient E-Fit study, launched in March, is designed to supplement Nexstim’s already complete Niche study. The Finnish company originally expected to conclude the E-Fit supplemental during the 1st quarter next year, but said today that “start-up issues” at some of the 5 U.S. sites “created a slight delay in the enrollment rate.” Read more
3. Sirtex SIR-Spheres fail to improve survival in colorectal trial
Sirtex Medical saw shares tumble more than 25% today after a trial of its radioactive microspheres reported no effect in improving survival in patients with colorectal cancer.
Results from the Foxfire analysis study indicated that the use of SIR-Spheres Y-90 microspheres in combination with chemotherapy did not improve overall survival in patients with unresectable colorectal cancer compared to chemotherapy alone, the Woburn, Mass.-based company said. Read more
2. Robocath raises $5.2m for R-one robotic platform
Medical robotics start-up Robocath said today it has raised $5.2 million (EU €4.7 million) in a new round of funding.
The round was led by M Capital and Normandie Participations and joined by previous investors Go Capital and NCI, the Rouen, France-based company said. Read more
1. New FDA commish extends time for comments on off-label communication rules
Under the agency’s new commissioner, Dr. Scott Gottlieb, the FDA has reportedly extended the time for comments in its review of off-label communication rules.
In the past, Gottlieb has advocated for off-label uses of medical products, arguing that doctors are adequately trained to make decisions in the best interest of their patients. Read more
The post MassDevice.com +5 | The top 5 medtech stories for May 19, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2pTXZve
Cap comentari:
Publica un comentari a l'entrada